zhuangzhuang zhang
University of Kentucky
Lexington, United States
Review Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Review Editors
weixing zhao
People's Liberation Army General Hospital
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
zhigang zhao
National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital
Tianjin, China
Review Editor
Cancer Molecular Targets and Therapeutics
honggang zheng
Department of Oncology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences
Beijing, China
Review Editor
Cancer Molecular Targets and Therapeutics
ying zhi
Shandong First Medical University
Tai'an, China
Review Editor
Cancer Molecular Targets and Therapeutics
chenjing zhu
Jiangsu Cancer Hospital, Nanjing Medical University
Nanjing, China
Review Editor
Cancer Molecular Targets and Therapeutics
jiang zhu
Qilu Hospital, Shandong University
Jinan, China
Review Editor
Cancer Molecular Targets and Therapeutics
xu-dong zhu
McMaster University
Hamilton, Canada
Review Editor
Cancer Molecular Targets and Therapeutics
zhenjian zhuo
Shenzhen Graduate School, Peking University
Shenzhen, China
Review Editor
Cancer Molecular Targets and Therapeutics
marcin ziętek
Wroclaw Medical University
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics
odete a b da cruz e silva
University of Aveiro
Aveiro, Portugal
Review Editor
Cancer Molecular Targets and Therapeutics
jasper de boer
Hudson Institute of Medical Research
Clayton, Australia
Review Editor
Cancer Molecular Targets and Therapeutics
agnieszka śmieszek
Wroclaw University of Environmental and Life Sciences
Wrocław, Poland
Review Editor
Cancer Molecular Targets and Therapeutics